Alliancebernstein L.P. Sutro Biopharma, Inc. Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 75,300 shares of STRO stock, worth $222,888. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,300

Previous 75,300 -0.0%

Holding current value

$222,888

Previous $323,000 31.58%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$3.29 - $4.9 $11,482 - $17,101	3,490 Added 4.86%	75,300 $261,000
Q2 2023 Aug 15, 2023	BUY	$4.25 - $5.88 $86,742 - $120,010	20,410 Added 39.71%	71,810 $333,000
Q4 2022 Feb 14, 2023	BUY	$5.41 - $8.08 $17,853 - $26,664	3,300 Added 6.86%	51,400 $415,000
Q3 2022 Nov 15, 2022	BUY	$5.17 - $7.11 $81,686 - $112,338	15,800 Added 48.92%	48,100 $267,000
Q2 2022 Aug 15, 2022	SELL	$3.41 - $8.95 $592,057 - $1.55 Million	-173,624 Reduced 84.31%	32,300 $168,000

Q1 2022 May 13, 2022	SELL	$7.78 - $15.31 $75,014 - $147,619	-9,642 Reduced 4.47%	205,924 $1.69 Million
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $155,168 - $256,218	10,889 Added 5.32%	215,566 $3.21 Million
Q3 2021 Nov 10, 2021	BUY	$16.88 - $22.38 $1.59 Million - $2.11 Million	94,320 Added 85.47%	204,677 $3.87 Million
Q2 2021 Jul 30, 2021	BUY	$18.03 - $23.82 $388,239 - $512,916	21,533 Added 24.24%	110,357 $2.05 Million
Q1 2021 May 06, 2021	BUY	$20.29 - $27.54 $1.48 Million - $2.01 Million	72,924 Added 458.64%	88,824 $2.02 Million
Q4 2020 Feb 08, 2021	BUY	$10.16 - $23.98 $31,496 - $74,338	3,100 Added 24.22%	15,900 $345,000
Q2 2020 Aug 13, 2020	BUY	$7.24 - $11.05 $92,672 - $141,440	12,800 New	12,800 $99,000

Others Institutions Holding STRO

# of Institutions

122

Shares Held

53.3M

Call Options Held

7.8K

Put Options Held

2.4K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $154M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Sutro Biopharma, Inc. Transaction History